Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Artificial Intelligence

AI can already diagnose depression better than a doctor and tell you which treatment is best

by Sarah Hellewell
December 27, 2023
in Artificial Intelligence, Depression
(Photo credit: Adobe Stock)

(Photo credit: Adobe Stock)

Share on TwitterShare on Facebook
Stay informed on the latest psychology and neuroscience research—follow PsyPost on LinkedIn for daily updates and insights.

Artificial intelligence (AI) is poised to revolutionise the way we diagnose and treat illness. It could be particularly helpful for depression because it could make more accurate diagnoses and determine which treatments are more likely to work.

Some 20% of us will have depression at least once in our lifetimes. Around the world,
300 million people are currently experiencing depression, with 1.5 million Australians likely to be depressed at any one time. Because of this, depression has been described by the World Health Organization as the single biggest contributor to ill health around the world.

So how exactly could AI help?

Depression can be hard to spot

Despite its frequency, depression is difficult to diagnose. So hard, in fact, that general practitioners accurately detect depression in less than half of cases.

This is because there is no one test for depression: doctors use self-reported symptoms, questionnaires and clinical observations to make a diagnosis. But symptoms of depression are not the same for everyone. Some people may sleep more, others sleep less; some people lack energy and interest in activities, while others may feel sad or irritable.

For those who are accurately diagnosed with depression, there are a range of treatment options including talk therapy, medications and lifestyle change. However, response to treatment is different for each person, and we have no way to know ahead of time which treatments will work and which won’t.

AI trains computers to think like humans, with a particular focus on three human-like behaviours: learning, reasoning and self-correction (to fine-tune and improve performance over time). One branch of AI is machine learning, the goal of which is to train computers to learn, find patterns in data and make data-informed predictions without guidance from humans.

In recent years there has been a surge in research applying AI to illnesses like depression, which can be difficult to diagnose and treat.

What they’ve found so far

Scientists have compared ChatGPT diagnoses and medical recommendations to those of real-life doctors with surprising results. When given information on fictional patients of varied depression severity, sex and socioeconomic status, ChatGPT mostly recommended talk therapy. In contrast, doctors recommended antidepressants.

US, British and Australian guidelines recommend talk therapy as the first treatment option ahead of medication.

This suggests ChatGPT may be more likely to follow clinical guidelines, whereas GPs may have a tendency to overprescribe antidepressants.

ChatGPT is also less influenced by sex and socioeconomic biases, while doctors are statistically more likely to prescribe antidepressants to men, especially those in blue-collar jobs.

How depression affects the brain

Depression affects specific parts of the brain. My research has shown that the areas of the brain affected by depression are extremely similar in different people. So much so, we can predict whether someone has depression or not with more than 80% accuracy just by looking at these brain structures on MRI scans.

Other research using advanced AI models has supported this finding, suggesting brain structure may be a helpful direction for AI-based diagnosis.

Studies using magnetic resonance imaging (MRI) data on brain function at rest can also predict depression correctly more than 80% of the time.

However, combining functional and structural information from MRI gives the best accuracy, correctly predicting depression in over 93% of cases. This suggests using multiple brain imaging techniques for AI to detect depression may be the most viable way forward.

MRI-based AI tools are currently only used for research purposes. But as MRI scans become cheaper, faster and more portable, it’s likely this kind of technology will soon be part of your doctor’s toolkit, helping them to improve diagnosis and enhance patient care.

The diagnostic tools you might have already

While MRI-based AI applications are promising, a simpler and easier method of detecting depression may be at hand, quite literally.

Wearable devices like smart watches are being investigated for their ability to detect and predict depression. Smart watches are especially helpful because they can collect a wide variety of data including heart rate, step counts, metabolic rate, sleep data and social interaction.

A recent review of all studies done so far on using wearables to assess depression found depression was correctly predicted 70–89% of the time. Since they are commonly used and worn around the clock, this research suggests wearable devices could provide unique data that might otherwise be hard to collect.

There are some drawbacks, however, including the substantial cost of smart devices which may be inaccessible to many. Others include the questioned ability of smart devices to detect biological data in people of colour and the lack of diversity in study populations.

Studies have also turned to social media to detect depression. Using AI, scientists have predicted the presence and severity of depression from the language of our posts and community memberships on social media platforms. The specific words that were used predicted depression with up to 90% success rates in both English and Arabic. Depression has also been successfully detected in its early stages from the emojis we use.

Predicting responses to treatment

Several studies have found antidepressant treatment response could be predicted with more than 70% accuracy from electronic health records alone. This could provide doctors with more accurate evidence when prescribing medication-based treatments.

Combining data from people in trials for antidepressants, scientists have predicted whether taking medications will help specific patients go into remission from depression.

AI shows substantial promise in the diagnosis and management of depression, however recent findings require validation before they can be relied upon as diagnostic tools. Until then, MRI scans, wearables and social media may be helpful to assist doctors diagnose and treat depression.The Conversation

 

This article is republished from The Conversation under a Creative Commons license. Read the original article.

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

AI chatbots often misrepresent scientific studies — and newer models may be worse
Artificial Intelligence

AI chatbots often misrepresent scientific studies — and newer models may be worse

May 20, 2025

AI-driven summaries of scientific studies may be misleading the public. A new study found that most leading language models routinely produce overgeneralized conclusions, with newer versions performing worse than older ones—even when explicitly prompted to avoid inaccuracies.

Read moreDetails
Optimistic individuals are more likely to respond to SSRI antidepressants
Depression

Optimistic individuals are more likely to respond to SSRI antidepressants

May 19, 2025

People with depression who were more optimistic at the start of treatment—and whose optimism increased during treatment—were more likely to benefit from SSRIs, according to a recent study, raising the possibility of tailoring treatments based on psychological traits.

Read moreDetails
Inhaled DMT produces rapid and lasting antidepressant effects in treatment-resistant depression
Ayahuasca

Inhaled DMT produces rapid and lasting antidepressant effects in treatment-resistant depression

May 17, 2025

Vaporized DMT produced fast and lasting improvements in depression symptoms and suicidal ideation, according to a new phase 2a trial, highlighting its potential as a scalable, non-invasive alternative to conventional and long-acting psychedelic treatments for severe depression.

Read moreDetails
New research points to gut serotonin as a potential way to treat depression and anxiety
Depression

New research points to gut serotonin as a potential way to treat depression and anxiety

May 16, 2025

New research reveals that serotonin in the gut lining can reduce anxiety and depression symptoms in mice—without the side effects of traditional antidepressants—and may offer a safer alternative for treating mood disorders during pregnancy.

Read moreDetails
Generative AI simplifies science communication, boosts public trust in scientists
Artificial Intelligence

Artificial confidence? People feel more creative after viewing AI-labeled content

May 16, 2025

A new study suggests that when people see creative work labeled as AI-generated rather than human-made, they feel more confident in their own abilities. The effect appears across jokes, drawings, poems, and more—and might stem from subtle social comparison processes.

Read moreDetails
New research links postnatal depression to a disrupted oxytocin response during breastfeeding
Depression

New research links postnatal depression to a disrupted oxytocin response during breastfeeding

May 15, 2025

A new study finds that postnatal depression may impair the body’s hormonal response to breastfeeding. While oxytocin nasal spray boosted breast milk levels in healthy mothers, the same effect was not seen in those experiencing depressive symptoms after childbirth.

Read moreDetails
Stress-induced “fixated” eating patterns linked to dopamine disruption, study finds
Depression

New research links antidepressant effects of escitalopram to endocannabinoid system changes

May 12, 2025

In a rodent model of childhood adversity, escitalopram treatment during adolescence reduced signs of emotional distress. The study also found gene-level changes in the endocannabinoid system, pointing to a possible biological mechanism for the drug’s effectiveness.

Read moreDetails
Antidepressants may diminish psilocybin’s effects even after discontinuation
Depression

A single dose of psilocybin might help reduce symptoms in treatment-resistant depression

May 12, 2025

A new open-label study suggests that a single dose of psilocybin, combined with psychological support, may reduce symptoms in people with severe treatment-resistant depression. Improvements were sustained for up to 12 weeks, although effects were weaker in those with PTSD.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

What brain scans reveal about the neural correlates of pornography consumption

AI chatbots often misrepresent scientific studies — and newer models may be worse

Is gender-affirming care helping or harming mental health?

Study finds “zombie” neurons in the peripheral nervous system contribute to chronic pain

Therapeutic video game shows promise for post-COVID cognitive recovery

Passive scrolling linked to increased anxiety in teens, study finds

Your bodily awareness guides your morality, new neuroscience study suggests

Where you flirt matters: New research shows setting shapes romantic success

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy